Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Knight Therapeutics Inc T.GUD

Alternate Symbol(s):  KHTRF

Knight Therapeutics Inc. is a specialty pharmaceutical company. The Company’s principal business activity is developing, acquiring, in-licensing, out-licensing, manufacturing, marketing and distributing pharmaceutical products in Canada, Latin America and select international markets. It finances other life sciences companies and secures product distribution rights for Canada and select international markets. The Company invests in life sciences venture capital funds whereby the Company may receive preferential access to healthcare products for Canada and select international markets. It develops pharmaceutical products, including those to treat neglected tropical and rare pediatric diseases. The portfolio consists of pharmaceutical products with molecules and includes both in-licensed products such as Lenvima, Cresemba, Halaven, Trelstar, Akynzeo, Ambisome, Minjuvi, Imvexxy as well as products owned by Knight such as Exelon and Impavido.


TSX:GUD - Post by User

Comment by MrMugsyon Jan 08, 2021 11:55pm
116 Views
Post# 32260390

RE:RE:RE:RE:RE:RE:RE:$5.6 Billion move into big pharma by Berkshire

RE:RE:RE:RE:RE:RE:RE:$5.6 Billion move into big pharma by Berkshire
Snowballgrowth wrote:
Chianchin wrote: Me think Mrmugsy, Goldinvestor and wagyusteak same person and possibly paid PR for GUD Management. I sold and gone. Very bad company and same aliias promoter on board. No beleive these three alias 


Another investor gone. We see some "fatigue" and impatience from investors these days. 



Snowball ... Chianchin is definately a fictitional character.  You can bank on that.  Just showed up one day after Clueless was banned.  Said she didn't have any shares - was just looking.  Just have a look at her history (I can't see it anymore as I put her on ignore).  She has never visited any other stock.  Hahaha - who comes from mainland China and makes their first and only stop at GUD?  That's when I knew the game ... her first message here.

Don't fear what the haters are saying.  I can't figure out why they even come here - but - when they called me a company man and thought I was getting paid to be here ... I realized their logic was horrible.  Simply awful.  Hahaha.

This company hasn't made any mistakes yet.
And remember, not enough shares to make Goodman change his plan.
The majority of the shares are counting on him finishing what he started.
You'll see at the next AGM vote.

You just need to decide if you've got thick enough skin to go for this ride - OR - if it's too mentally draining.  That's all there is to this one.

: )

<< Previous
Bullboard Posts
Next >>